Immix Biopharma Inc.

1.67
-0.03 (-1.76%)
At close: Mar 31, 2025, 3:59 PM
1.60
-3.90%
After-hours: Mar 31, 2025, 06:48 PM EDT

Immix Biopharma Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a -89.52M n/a n/a n/a
Cost of Revenue n/a 5.47K 2.13K 2.47K 2.32K 1.08K
Gross Profit n/a -5.47K -89.52M -2.47K -2.32K -1.08K
Operating Income -22.67M -16.14M -8.22M -1.35M -453.85K -842.5K
Interest Income 1.02M 572.01K 0.50 179.85 101.98 109.98
Pretax Income -21.66M -15.57M -8.22M -24.38M -1.13M -952.26K
Net Income -21.61M -15.43M -8.23M -24.38M -1.15M -972.81K
Selling & General & Admin 11.38M 7.41M 4.02M 1.23M 205.7K 259.34K
Research & Development 11.29M 8.74M 4.2M 126.53K 248.15K 583.16K
Other Expenses n/a n/a n/a n/a 512.00 224.00
Operating Expenses 22.67M 16.14M 8.22M 1.35M 453.85K 842.5K
Interest Expense n/a n/a 497.00 179.85K 101.98K 109.98K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 16.14M 8.22M 1.35M 453.85K 842.5K
Income Tax 41.04K 26.41K 10.27K 6.01K 17.55K 20.55K
Shares Outstanding (Basic) 28.29M 17.34M 13.23M 13.23M 7.77M 3.38M
Shares Outstanding (Diluted) 28.29M 17.34M 13.23M 13.23M 7.77M 3.38M
EPS (Basic) -0.76 -0.89 -0.62 -1.84 -0.15 -0.29
EPS (Diluted) -0.76 -0.89 -0.62 -1.84 -0.15 -0.29
EBITDA -22.67M -16.14M -8.22M -1.35M -451.53K -841.2K
Depreciation & Amortization n/a 5.47K 2.13K 2.47K 2.32K 1.08K